Articles tagged with Scientific Workforce
Dr. Randy J. Nelson's research reveals that artificial light exposure disrupts immune function, causes neuroinflammation, and influences mood regulation. His work has significant implications for understanding depression and anxiety disorders, as well as the obesity epidemic.
Gene coexpression analysis reveals optimal markers of cell types and states, providing opportunities for developing novel biomarkers and targeted treatment strategies for glioma patients. Dr. Oldham's work tackles the reproducibility crisis in science, emphasizing data metadata standardization.
Dr. Xuyu Qian's pioneering research using MERFISH technology created an unprecedented developmental atlas of the human cerebral cortex, analyzing over 18 million single cells. His work aims to identify mechanisms disrupted in conditions like malformations and autism spectrum disorder.
A Brazilian researcher is studying induced pluripotent stem cells from centenarians to understand cellular resilience in COVID-19 survivors. The study aims to identify key cellular pathways that influence longevity and potentially contribute to therapeutic approaches for age-related diseases.
Dr. Eric Sun's groundbreaking work uses spatial aging clocks to measure biological age at the individual cell level, identifying specific cell types that drive brain aging in neighboring tissues. His machine learning models reveal complex intercellular communication networks that determine aging rates.
Sara Poletti's research reveals how childhood trauma triggers persistent neuroinflammation pathways and alters brain structure, creating lifelong vulnerability to psychiatric disorders. Her work identifies biological markers of trauma and explores prevention strategies to reduce mental illness odds.
Dr. John Oldham's contributions have fundamentally reshaped personality disorder classification, moving from rigid categories to a more nuanced dimensional system. His Alternative DSM-5 Model for Personality Disorders (AMPD) has marked the most significant epistemological shift in psychiatric diagnosis for decades.
A pioneering research brings psychedelic medicine into gastroenterology, exploring psilocybin's effects on treatment-resistant irritable bowel syndrome (IBS). Dr. Erin E. Mauney's study modulates interoception and uses integrated therapy sessions with neuroimaging to track brain changes.
Professor Benedetti's research explores the intersection of genetics, environmental factors, and treatment response in mood disorders. His work has led to breakthroughs in chronotherapeutics and immuno-psychiatry, revealing crucial insights into immune-inflammatory mechanisms and gene variants influencing brain function.
A decrease in first-generation students was found among U.S. medical student matriculants, with high risks of attrition due to intersectional factors. This study emphasizes the need for targeted recruitment and retention efforts to better reflect physician workforce diversity.
Researchers have found that psychedelic compounds can reverse a cascade involving brain-resident cells and immune cells, increasing fear behavior when chronic stress disrupts signaling. This finding represents a paradigm shift in understanding psychedelics' therapeutic potential.
Researchers using multi-omics tools analyze blood-derived immune cells to chart disease heterogeneity in unprecedented detail. This approach enables exploration of pre-existing immune states shaped by past infections, environmental exposures, and genetic predisposition.
Dr. Romina Mizrahi's PET-based neuroimaging sheds light on brain workings, integrating genetics, environment and imaging to understand psychiatric illness as a complex biological puzzle. She advocates for precision psychiatry paradigm with customized treatments based on molecular profiles, and calls for diversity in academic leadership.
Dr. Melissa Perreault's research combines cutting-edge science with Indigenous knowledge, pioneering sex-specific biomarkers, neuroethics, and psychedelics research in neuropsychiatry. Her work aims to promote inclusive methodologies that consider diverse worldviews and cultural understandings of health.
Joni Roberts, a Cal Poly Assistant Professor, has been chosen as the first recipient of the Faculty Excellence Award for her exceptional dedication to public health education and global health advocacy. Her research addresses health disparities and promotes equity, while her teaching spans the public health curriculum.
Dr. Kerry Ressler's research bridges the gap between molecular neuroscience and clinical psychiatry to understand PTSD's genetic architecture. Recent breakthroughs have identified over 100 significant genetic loci, representing a major step toward translating scientific discoveries into effective treatments.
Dr. Carrie Bearden's groundbreaking work combines genetic and brain development insights to identify early warning signs of psychosis in adolescents. Her research has exciting implications for personalized medicine and targeted preventive treatments.
Renowned neuroscientist Dr. Michael Meaney discusses his pioneering work on the intricate relationship between genes and environment in shaping brain health, with implications for public health policy and early intervention programs.
Emory University MD candidate Fayzan Rab's research investigates the economic and public health implications of psychedelic therapy implementation. His work emphasizes making these innovative treatments accessible to traditionally underserved communities.
Neuroscientist Professor Raz Yirmiya reveals a vital link between inflammation and depression through groundbreaking research. His work suggests that both activation and suppression of the immune system can trigger depressive symptoms, highlighting the need for personalized treatment approaches.
Dr. Cathy Barr's groundbreaking research sheds light on the genetic foundations of conditions including depression, ADHD, reading disabilities, and Tourette syndrome. Her work has the potential to lead to more targeted treatments and reduce stigma around psychiatric disorders.
Neuroscientist Inga Neumann discusses groundbreaking research on oxytocin, a neuropeptide that shapes social behavior and emotional responses. Her work has significant implications for treating social anxiety disorders and understanding stress resilience.
Renowned neuroscientist Dr. Peter Kalivas discusses his groundbreaking work on the tetrapartite synapse, a complex cellular structure influencing addictive behaviors. His research has revolutionized addiction treatment by identifying novel therapeutic targets beyond traditional neurotransmitter systems.
Dr. Munir Gunes Kutlu's groundbreaking research reveals specific neural mechanisms that transform sensory inputs into behavioral outputs. The discovery sheds light on the brain's dopamine system, particularly in processing information about environmental cues and rewards.
The Alliance of Hispanic-Serving Research Universities (HSRU) has received a $9.3 million grant from the U.S. Department of Defense to accelerate STEM education and research. The project, co-led by UCF and UTEP, aims to address the critical need for high-quality STEM talent in national defense.
Dr. Edo Ronald de Kloet shares insights on cortisol's dual role in protecting and damaging the brain through mineralocorticoid receptors (MR) and glucocorticoid receptors (GR). His discovery has transformed our understanding of stress-related mental disorders and led to novel therapeutic pathways.
Professor Lavretsky's pioneering work integrates conventional psychiatric treatments with mind-body interventions, developing novel therapeutic combinations for treatment-resistant depression and cognitive disorders. Her research has transformed approaches to mental health and aging, emphasizing whole person health and prevention.
Research by Prof. Falkai suggests promising new directions in schizophrenia treatment through brain plasticity and myelin regeneration. His work challenges traditional views of the disorder and opens new therapeutic possibilities, particularly when combining aerobic exercise with a repurposed drug.
Dr. Natalia Acosta-Baena has identified a novel genetic syndrome that reshapes our understanding of brain disorders and challenges traditional views on neurodevelopmental disorders and neurodegeneration. Her research reveals how a single gene involved in neuronal transport can influence both brain development and degeneration.
Dr. Etienne Sibille's work develops novel therapeutics for cognitive deficits in depression and age-related disorders through Damona Pharmaceuticals, a biopharma company he co-founded.
Professor Amal's research has uncovered crucial links between autism spectrum disorder (ASD) and Alzheimer's disease, suggesting shared molecular mechanisms that could revolutionize treatment approaches. He is developing biological diagnostics and treatments for ASD through his biotechnology companies, Point6 Bio Ltd and NeuroNOS Ltd.
Dr. Volkow emphasizes the importance of prevention strategies and research on stress, trauma, and social determinants in substance use disorders. She also highlights promising new directions in treatment, including GLP1 medications, to address the treatment gap in addiction.
Dr. Andreazza's work focuses on identifying biomarkers for personalized treatments in metabolic psychiatry, with breakthroughs in brain organoids and mitochondrial transplantation techniques. Her innovative approach aims to revolutionize treatment for both psychiatric and metabolic disorders.
Dr. Reichlin's groundbreaking work on brain-hormone interactions and his influence on generations of endocrinologists are being celebrated through a Festschrift series in Brain Medicine. The series explores multiple facets of his contributions, including pioneering work on hypothalamic control of pituitary function and early recognitio...
The University of Arizona's eCAMINOS program uses asset-based mentoring to help students identify their strengths and showcase their skills in portfolios. This approach has been shown to promote student success and create a more inclusive learning environment in engineering.
Dr. Lutz's pioneering research combines genetic engineering, multiomics, and bioinformatics to understand epigenetic mechanisms underlying psychiatric conditions like addiction and depression. His work aims to bridge the gap between genomics and behavior.
A study found that Medicaid expansion primarily benefits higher-earning healthcare workers, with no notable effects on lower-wage staff. The findings suggest a potential widening of economic inequality within the healthcare sector.
The University of Texas at Arlington has selected 16 undergraduate students to join the McNair Scholars Program, a Department of Education-funded grant. The program prepares students for careers in academic research with a stipend, summer research internship, and mentorship from UTA faculty.
A recent survey found that 18.5% of Ukrainian scientists had left the country since the start of the war, with those more productive and research-active being more likely to emigrate. The average time spent on research activities reduced from 13 hours to 10 hours, equating to a loss of about 20% of scientific research capacity.
The ARC Centre of Excellence for Transformative Meta-Optical Systems is launching a special measures recruitment round exclusively for women and gender-diverse candidates. The initiative aims to increase the participation of women in STEM fields, with the goal of achieving 40% gender diversity by 2026.
The Cumming Global Centre for Pandemic Therapeutics is offering global grants of up to $200,000 per annum for three years to develop novel therapeutics for pathogens of pandemic potential. Researchers are invited to submit expressions of interest for Round Two of the Foundation Grants program.
Research by a University of Illinois expert found that high-ability tech workers join startups due to expected non-monetary benefits, not just lower pay. Startups can recruit top talent despite offering less compensation, suggesting a preference for the startup culture and environment.
The University of Missouri is launching a five-year, $3 million doctoral training program to prepare the next generation of scientists and engineers for emerging fields like materials science and data science. The program aims to empower future workers with both technical expertise and data-driven insights.
The University of Missouri is using a $1 million grant to develop an Industry 4.0 lab, providing engineering students with hands-on learning experiences in the latest industrial revolution's technology-centered job market. The lab will integrate skills at a higher level and keep students at the state-of-the-art level for industry.
A special issue of Health Equity journal explores ways to promote diversity, equity, and inclusion in healthcare for veterans. Research highlights successful initiatives, such as a biweekly Diversity Equity and Inclusion Working Group meeting, and a 5-fold increase in women Veteran enrollment in the VA Million Veteran Program.
Physicist Sekazi Mtingwa recognized for promoting accessibility, diversity, and equity in STEM. He co-developed the Bjorken-Mtingwa formulation solving intrabeam scattering effects, enabling more efficient particle accelerators.
Researchers at Binghamton University propose a three-pillar approach to increase inclusion in STEM fields, including flexibility, accommodation, and modification. This framework aims to address the diverse needs of individuals with disabilities and other constraints.
A study by physicists Fariba Karimi and her team has confirmed that women are underrepresented in physics, but found that the gender gap is largely due to a first-mover advantage enjoyed by men. The research suggests that women face higher entry barriers and structural inequalities, leading to differences in citation recognition.
Women pursuing careers in entomology face persistent challenges in obtaining jobs compared to men. The study found that men published more research articles and were first authors on average, leading to higher H-index scores. Women are also less likely to hold industry positions as technical representatives and research scientists.
A new study found that scientists tend to be most innovative and creative early in their careers, with a significant decline in impact over the course of their careers. The study analyzed 5.6 million biomedical science articles and found that the work of less-innovative researchers tends to drop out as they get older.
Training programs for science, technology, engineering, and mathematics (STEM) workers are becoming increasingly important to address labor shortages in technical roles. Community colleges and apprenticeships are partnering with regional companies to provide career opportunities for aspiring chemists.
A new study using a large dataset from universities reveals that women are less likely than men to receive authorship credit for their work, particularly in early stages of their careers. Women were also less likely to be listed as authors on high-impact articles and faced underestimation of their contributions.
A recent commentary by Dartmouth College's Bala Chaudhary highlights the challenges faced by women researchers who choose to get married and change their last names. The lack of a consistent way to update publication records can lead to biases in grant and tenure applications, potentially affecting career advancement.
Lehigh University will lead a five-year, $25 million research collaboration to develop new semiconductor materials and scalable manufacturing processes for advanced optoelectronic devices. The initiative aims to transform fields like information technology with quantum technologies.
A new study by NIH scientists found that research topic preference accounts for over 20% of the persistent funding gap between black and white researchers. Black applicants are more likely to propose topics with lower success rates, such as health disparities research and patient-focused interventions.